Sfoglia per AUTORE
FORCADE E
Collezione AOU Città della Salute di Torino

  

Items : 7

2024
AOU Città della Salute di Torino

Devillier R; Galimard JE; Blaise D; Raiola AM; Bramanti S; Grillo G; Pastano R; de Latour RP; Busca A; López-Corral L; Rodríguez AB; Schmid C; Forcade E; Vydra J; Solano C; Bug G; Neubauer A; Charbonnier A; Brissot E; Nagler A; Ciceri F; Mohty M;

2023
AOU Città della Salute di Torino

Kharfan-Dabaja MA; Labopin M; Ayala E; Bazarbachi A; Blaise D; Vydra J; Bramanti S; Itälä-Remes M; Schmid C; Busca A; Forcade E; Rabitsch W; Zecca M; Kröger N; Bulabois CE; Grillo G; Rambaldi A; Fanin R; Zallio F; Di Renzo N; Koc Y; Novis Y; McDonald A; Herrera Arroyo C; Sanz J; Nagler A; Ciceri F; Mohty M;

2022
AOU Città della Salute di Torino

Neubauer A; Avenoso D; Yakoub-Agha I; Arroyo H; Bay JO; Olivieri A; Vrhovac R; Charbonnier A; Bruno B; Bug G; Stölzel F; Martino M; Chalandon Y; Socié G; Castagna L; Pavlu J; Raiola AM; Blaise D; Labopin M; Galimard JE; Devillier R; Nguyen S; Forcade E; Brissot E; Savani B; Nagler A; Mohty M;

2022
AOU Città della Salute di Torino

Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M;

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug
2022
AOU Città della Salute di Torino

Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Nov;57(11):1657-1663. doi: 10.1038/s41409-022-01781-9. Epub 2022 Aug 17
2022
AOU Città della Salute di Torino

Simand C; Carella AM; Kulagin A; Passweg J; Rösler W; Forcade E; Chevallier P; Koc Y; Jindra P; Busca A; Stölzel F; Bulabois CE; Diez-Martin JL; Fanin R; Vydra J; Sica S; Raiola AM; Blaise D; Ciceri F; Tischer J; Labopin M; Baron F; Bazarbachi A; Pioltelli P; Nagler A; Mohty M;

2022
AOU Città della Salute di Torino

Forcade E; Choi G; Corral LL; Tischer J; Martin H; Pavlu J; Arat M; Socié G; Nguyen S; Bulabois CE; Grillo G; Araujo MC; Martino M; Moiseev I; Rovira M; Bruno B; Castagna L; Sica S; Diez-Martin JL; Vitek A; Gülbas Z; Koc Y; Ruggeri A; Raiola AM; Blaise D; Labopin M; Galimard JE; Battipaglia G; McDonald A; et alii...